NEW YORK, July 26- Invitrogen announced a significant increase in second quarter revenues relative to the year ago period, largely due to the contribution of its newly acquired company, Life Technologies, the company announced on Thursday.

Invitrogen also posted a net loss of $35.1 million, or 67 cents per share, during this latest financial period, compared to a net income of $4.8 million in the second quarter, 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.